Trial intelligence / Profile preview

Glutamine supplementation in high-risk cardiothoracic surgery

2006-004217-18Phase 4Active

Sponsor
Leiden University Medical Center
Start
Aug 2006
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 4 trial of alanyl glutamine in surgical site infection (SSI), sponsored by Leiden University Medical Center. Primary endpoint: Infectious complications during ICU and hospital stay. Started Aug 2006; status: active.

02

Drugs

alanyl glutamine
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on 2006-004217-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004217-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call